Bio-Techne Corp

TECH

Company Profile

  • Business description

    Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

  • Contact

    614 McKinley Place N.E.
    MinneapolisMN55413
    USA

    T: +1 612 379-8854

    https://www.bio-techne.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 June 2026

    Employees

    3,100

Stocks News & Analysis

stocks

Lowering profit forecasts on Aussie airlines

The impact of the oil price surge.
stocks

AI isn’t an economic moat killer, but it will disrupt industries

How we’re rethinking companies’ competitive advantages in an AI-first world.
stocks

AI lands a blow on some Aussie stocks – yet stands to benefit others

AI is reshaping ASX tech moats - but some are more insulated than others.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,571.30125.30-1.44%
CAC 407,697.2928.91-0.37%
DAX 4022,447.08206.78-0.91%
Dow JONES (US)46,208.47631.001.38%
FTSE 1009,868.4525.70-0.26%
HKSE25,063.71681.242.79%
NASDAQ21,946.76299.151.38%
Nikkei 22552,252.28736.791.43%
NZX 50 Index12,701.75197.97-1.53%
S&P 5006,581.000.000.00%
S&P/ASX 2008,379.40125.20-1.47%
SSE Composite Index3,881.2868.001.78%

Market Movers